MVP Stock Overview
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Medical Developments International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.47 |
52 Week High | AU$1.83 |
52 Week Low | AU$0.46 |
Beta | 1.61 |
1 Month Change | -21.19% |
3 Month Change | -44.64% |
1 Year Change | -51.81% |
3 Year Change | -91.67% |
5 Year Change | -91.45% |
Change since IPO | -61.89% |
Recent News & Updates
Recent updates
Shareholder Returns
MVP | AU Pharmaceuticals | AU Market | |
---|---|---|---|
7D | -15.5% | 1.0% | -0.3% |
1Y | -51.8% | 31.1% | 6.1% |
Return vs Industry: MVP underperformed the Australian Pharmaceuticals industry which returned 31.1% over the past year.
Return vs Market: MVP underperformed the Australian Market which returned 6.1% over the past year.
Price Volatility
MVP volatility | |
---|---|
MVP Average Weekly Movement | 7.5% |
Pharmaceuticals Industry Average Movement | 10.7% |
Market Average Movement | 9.0% |
10% most volatile stocks in AU Market | 17.7% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: MVP's share price has been volatile over the past 3 months.
Volatility Over Time: MVP's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1971 | n/a | Brent MacGregor | medicaldev.com |
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices.
Medical Developments International Limited Fundamentals Summary
MVP fundamental statistics | |
---|---|
Market cap | AU$39.70m |
Earnings (TTM) | -AU$19.21m |
Revenue (TTM) | AU$33.55m |
1.2x
P/S Ratio-2.1x
P/E RatioIs MVP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MVP income statement (TTM) | |
---|---|
Revenue | AU$33.55m |
Cost of Revenue | AU$10.17m |
Gross Profit | AU$23.38m |
Other Expenses | AU$42.59m |
Earnings | -AU$19.21m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.22 |
Gross Margin | 69.69% |
Net Profit Margin | -57.27% |
Debt/Equity Ratio | 0% |
How did MVP perform over the long term?
See historical performance and comparison